FOS-like antigen 1 is a prognostic biomarker in hepatocellular carcinoma
Conclusions: High expression of FOSL1 is an independent risk factor of HCC predicting unfavorable prognosis, indicating that FOSL1 detection could stratify patients with high risk, and anti-FOSL1 therapy may be a promising way to treat HCC.
Source: The Saudi Journal of Gastroenterology - Category: Gastroenterology Authors: Li Li Wenqi Zhang Shanshan Zhao Mao Sun Source Type: research
More News: Cancer & Oncology | Carcinoma | Gastroenterology | Hepatitis | Hepatitis B | Hepatocellular Carcinoma | Liver Cancer | Middle East Health | Saudi Arabia Health | Study